Skip to main content
. Author manuscript; available in PMC: 2022 Jun 1.
Published in final edited form as: Curr Opin Biotechnol. 2021 Jan 18;69:145–152. doi: 10.1016/j.copbio.2020.12.011

Figure 2. Refactoring biosynthetic gene clusters for novel NP discovery or yield optimization of clinically relevant drugs.

Figure 2.

BGC, biosynthetic gene cluster; HR, homologous recombination; NP, natural product; LC-MS, liquid chromatography-mass spectrometry.